In line with the previous research of our research group, colon cancer CT26.WT was selected for the transwell assay, and the transwell assay results showed that treatment with IL-4-conditioned medium (CM) obviously enhanced the migratory ability of the cells when compared with the control group. This evidence concerns the gene IL4 and malignant colon neoplasm.